Data as of Sep 29, 2026 · Based on 94 AI responses · See how Parse measures this
Stone Steps Financial provides comprehensive financial life planning and investment management tailored to each client's unique needs. The firm uses a five-step process to create personalized roadmaps, helping clients align their money with their ideal lives.
1%0% before. Up 1 point.
of AI answers about Stone Steps Financial and its rivals. Week of Sep 21
The market map · 5 of 100 labelled
Fee-Only Fiduciary Financial PlannersMentioned in · last 30 days
“Stone Steps Financial : Exceptionally well-regarded for handling complex equity structures like ISOs, RSUs, pre-IPO stock, and deferred compensation without product or commission conflicts.”
“Stone Steps Financial : A boutique fee-only firm tailored specifically to tech and biotech executives . They focus heavily on the intersection of concentrated stock positions, complex equity structures, and high-income tax mitigation.”
“Stone Steps Financial - A fee-only, fiduciary firm focusing heavily on tech and biotech equity complexities, pre-IPO equity, and holistic life/tax planning.”
I need to get my finances in order. How do I find a fee-only financial planner?
National Association of Personal Financial Advisors (NAPFA)Garrett Planning NetworkXY Planning Network
I need to hire a retirement advisor. How do I find a fee-only fiduciary near me?
National Association of Personal Financial Advisors (NAPFA)
AI mentioned Stone Steps Financial in 1% of answers about Stone Steps Financial and its rivals in the week of Sep 21.
Where Stone Steps Financial ranks in AI
National Association of Personal Financial Advisors (NAPFA) is the top alternative to Stone Steps Financial
Excerpts where Stone Steps Financial appeared in the AI's answer
Stone Steps Financial : Exceptionally well-regarded for handling complex equity structures like ISOs, RSUs, pre-IPO stock, and deferred compensation without product or commission conflicts.
Stone Steps Financial : A boutique fee-only firm tailored specifically to tech and biotech executives . They focus heavily on the intersection of concentrated stock positions, complex equity structures, and high-income tax mitigation.